ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
236 hedge funds and large institutions have $3B invested in Array Biopharma Inc in 2018 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 74 increasing their positions, 74 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
236
Holders Change
+28
Holders Change %
+13.46%
% of All Funds
5.27%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.2%
New
57
Increased
74
Reduced
74
Closed
27
Calls
$31.1M
Puts
$12.4M
Net Calls
+$18.7M
Net Calls Change
+$10.1M
Top Buyers
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
2
State Street
Boston,
Massachusetts
|
$103M |
| 3 |
BI
3
BVF Inc
San Francisco,
California
|
$67.6M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$9.45M |
| 5 |
5
Morgan Stanley
New York
|
$31.8M |
